The Missing Ingredient for Big Tech's $3T Recipe?
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Shares Stats
| Shares Outstanding | 3,147,300,000 |
| Shares Float | 3,146,570,000 |
| Shares Short | 6,500,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.30% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 17.30 |
| Market Cap | 48,279,900,000 |
| PE Ratio | 70.59 |
| PEG Ratio | 0.43 |
| EBITDA | 1,233,261,953,024 |
Financials
| Profit Margin | 2.35% |
| Operating Margin | 13.02 |
| Return on Assets | 0.02 |
| Return on Equity | 0.02 |
| Revenue | 30.1B |
| Earnings Per Share | 0.23 |
| Revenue Per Share | 1,450.89 |
| Gross Profit | 3,010,131,918,848 |
| Quarterly Revenue Growth | 0.00 |
Valuation
| Trailing PE | 66.70 |
| Forward PE | 14.53 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 0.99 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.69 per share, with a dividend yield of 4.52%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 261.52% of their earnings out as a dividend.
Recent Dividends
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
| Dec 11, 2023 | $0.32 |
Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not
WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.
Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys
Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Marjorie Taylor Greene: 'Muslim Takeover' Threatens American Women
Rep. Marjorie Taylor Greene (R-Ga.) has expressed her fears regarding what she believes to be the most significant threat to the freedom of American women.
Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk
Bernie Sanders lost the 2016 and 2020 presidential races. In a recent interview, Sanders shared what he would do first if he were president.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
How Senate Republicans want to change the tax breaks in Trump's big bill
WASHINGTON (AP) — House and Senate Republicans are taking slightly different approaches when it comes to the tax cuts that lawmakers are looking to include in their massive
Kevin O'Leary Once Said That Business School Graduates Know Nothing Until The Real World Smacks Them, Something He Learned The Hard Way— Now He Can Spot A Winner In 15 Minutes Flat
Kevin O'Leary says real-world experience—not business school—taught him to trust his intuition, which now allows him to spot winning entrepreneurs in just 15 minutes with near-perfect accuracy.
Wall Street Says BUY GOLD, But... - Ad
While markets wobble, gold keeps smashing records-and banks say it's just beginning. Goldman urges "buy gold" to hedge trade wars; JPMorgan plans $6,000 an ounce and just took delivery of $4 billion in bullion. Yet past bull runs saw 13x-1,000x bigger gains without buying more gold.
Nike Beats The Street And Says The Worst Is Over
Nike Inc (NKE) stock rallies after upbeat fiscal Q4 results. Analysts maintain Buy ratings, raise price targets, citing potential for growth.
DOGE-Fame 'Big Balls' Is Reportedly Leaving The Government Department Once Headed By Elon Musk — Dogecoin Price Rises
Another key figure at the Department of Government Efficiency, nicknamed “Big Balls”, has reportedly stepped down, following the exit of Elon Musk from the federal initiative meant to reduce wasteful spending.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.
Home to North Carolina iconic attraction reopens after Hurricane Helene's devastation
CHIMNEY ROCK, N.C. (AP) — An iconic tourist attraction in an area of western North Carolina among the hardest hit by reopened to the public on Friday, nine months after the storm brought historic flooding, destruction and loss of life.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
Tried and tested in war: For European drone manufacturers, Ukraine is the place to be
LE BOURGET, France (AP) — About once a month, French manufacturer Henri Seydoux makes what has become a necessary pilgrimage for many in his business — he goes to .
Beyoncé and Jay-Z dominate Paris as celebrity drives fashion’s biggest trend
PARIS (AP) — If any force swept through the fashion industry this season — and sent shockwaves around the globe — it wasn’t a new silhouette or a daring color. It was the spectacle of celebrity.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Asian shares are mixed after US stocks hit an all-time high
BANGKOK (AP) — Asian shares started the week with gains after U.S. stocks closed at an all-time high following their recovery from the shocks of the Trump administration’s
Asia Markets Mixed, Europe Gains, Dollar Hit by Fed Concerns And Cooling Inflation - Global Markets Today While US Slept
US markets closed mixed on Wednesday, tech shares lifted Nasdaq while S&P 500 remained flat. Fed Chair Powell reiterated wait-and-see approach. Asian markets mostly up, European markets also positive with oil prices steady.
Fox: China Is Hiding a '401K Nuke Switch' Under Trump's Nose - Ad
China holds $784B in U.S. debt-and may trigger a dollar collapse. Gold is already soaring, with forecasts up to $6,000-$30,000. Protect your savings now. Claim the free 2025 Gold Guide and discover a Trump-era IRS loophole to buy gold tax- and penalty-free.
The Senate is putting Trump's big bill back on track but hurdles remain
WASHINGTON (AP) — Senate Republicans appeared Friday to push back on track after a flurry of last-minute revisions, including , but there's still a long way to go ahead of expected weekend votes.
Mark Cuban Raises Employee Wages After Learning Of Government Aid Dependence
Mark Cuban, owner of the NBA's Dallas Mavericks, expressed his dismay upon learning that some of his employees were reliant on government aid programs.
This Coin Could Surge Like Bitcoin Did Back in 2013... - Ad
A new coin is emerging in the crypto world. And investing in it now could end up like Bitcoin or Ethereum during their first bull runs.
Home Depot Eyes GMS Acquisition, Setting Stage For Bidding War With QXO
Home Depot wants to acquire GMS, sparking a potential bidding war with QXO in the construction materials space.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Trump's Crypto Ventures, Draper And Cathie Wood's Bitcoin Predictions, MSTR Estimates, And More: This Week In Crypto
The past week in the world of cryptocurrency was nothing short of eventful. From legislative moves aimed at curbing alleged corruption in cryptocurrency ventures to bold predictions about Bitcoin’s dominance, the week was filled with intriguing developments. Here’s a quick recap of the top stories that made headlines.
Tesla Vs. Meta: Engineer Says He's Staying At EV Giant — 'No Amount Of Money Can Sway Me From Elon'
Recruiting AI talent is leading to companies trying to steal employees from other tech giants. A Tesla engineer shared why he chose not to take a rival's job offer.
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Republicans hit major setback in their effort to ease regulations on gun silencers
WASHINGTON (AP) — Republican efforts to loosen regulations on and short-barreled rifles and shotguns have been dealt a big setback with the Senate parliamentarian advising that the proposal would need to clear a 60-vote threshold if included in their big tax and immigration bill.
Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses
Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, supporting further development.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Amy Coney Barrett Earns Trump's Credit After Court Ruling: 'I Have Great Respect For Her'
Trump praises Justice Barrett's Supreme Court ruling limiting nationwide injunctions, while blasting NYC's Mamdani and defending his economic agenda.
T-Mobile Stock (TMUS) Plunges After SoftBank's $4.8B Share Sale: Report
T-Mobile stock is down over 4% after SoftBank reportedly sold $4.8 billion in shares at a discount. This major share sale by a key investor is contributing significantly to the stock's decline Tuesday.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Dan Ives Urges Apple 'To Make A Move,' Saying That Perplexity Acquisition Is 'A No-Brainer': 'It's A Matter Of When And Not If'
Tech bull Daniel Ives has urged Tim Cook's Apple to make quick moves and acquire Perplexity AI for its search engine.
Reapply Or Wait? Servicer MOHELA Says New IDR Applications May Move Faster — Here's What You Need To Know
MOHELA, the Education Department's loan servicer, urges student loan holders to reapply for income-driven repayment plans filed before April 27, 2025 to expedite processing and cancel previous requests. However, this may result in administrative forbearance that does not count towards forgiveness.
Wall Street Says BUY GOLD, But... - Ad
While markets wobble, gold keeps smashing records-and banks say it's just beginning. Goldman urges "buy gold" to hedge trade wars; JPMorgan plans $6,000 an ounce and just took delivery of $4 billion in bullion. Yet past bull runs saw 13x-1,000x bigger gains without buying more gold.
Canada Threatens Higher Tariffs On US Steel, Aluminum If No Deal Is Reached By July 21, Mark Carney Says He's Ensuring Protection Against 'Unjust' US Levies
Canada is ramping up economic pressure on the U.S. with a fresh ultimatum as trade tensions escalate over steel and aluminum tariffs.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.